D-0058-2021 Class II Terminated
FDA drug recall D-0058-2021 was initiated by Direct Rx on Oct 12, 2020 and is designated Class II. Reason for recall: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) The recall status is terminated (terminated Sep 22, 2021). Affected quantity: 88 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2020
- Initiation Date
- Oct 12, 2020
- Termination Date
- Sep 22, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 88 bottles
Product description
Metformin HCL E/R 500 mg, 90 Tabs, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 72189-064-90
Reason for recall
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
Distribution pattern
FL
Code information
Lot: 04DE1902, 11DE1908 Exp. 06/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0058-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026